Michael P. Dube - 01 Jul 2024 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
VP, PAO and Interim PFO
Signature
/s/ James Basta, attorney-in-fact
Issuer symbol
NTLA
Transactions as of
01 Jul 2024
Net transactions value
$0
Form type
4
Filing time
03 Jul 2024, 13:15:03 UTC
Previous filing
22 Apr 2024
Next filing
04 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Award $0 +17,801 +57% $0.000000 49,024 01 Jul 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.